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Abdominal obesity in Japanese-Brazilians: which 
measure is best for predicting all-cause and 
cardiovascular mortality?
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Abstract
This study aimed to verify which anthropometric 
measure of abdominal obesity was the best pre-
dictor of all-cause and cardiovascular mortality 
in Japanese-Brazilians. The study followed 1,581 
subjects for 14 years. Socio-demographic, life-
style, metabolic, and anthropometric data were 
collected. The dependent variable was vital sta-
tus (alive or dead) at the end of the study, and the 
independent variable was presence of abdominal 
obesity according to different baseline measures. 
The mortality rate was estimated, and Poisson 
regression was used to obtain mortality rate ra-
tios with abdominal obesity, adjusted simultane-
ously for the other variables. The mortality rate 
was 10.68/thousand person-years. Male gender, 
age ≥ 60 years, and arterial hypertension were 
independent risk factors for mortality. The results 
indicate that prevalence of abdominal obesity 
was high among Japanese-Brazilians, and that 
waist/hip ratio was the measure with the greatest 
capacity to predict mortality (especially cardio-
vascular mortality) in this group.
Anthropometry; Abdominal Obesity; Mortality
Introduction
In developed and developing countries, obesity 
has become the fastest-growing nutritional and 
public health problem in recent years 1. In the 
United States in 2003-2004, 66.3% of Americans 
had some degree of excess weight 2. In Japan, data 
from the National Nutrition Survey showed that 
the prevalence rates for overweight and obesity 
among individuals 20 years or older were 24.5% 
and 2.3%, and 17.8% and 3.4%, for males and fe-
males, respectively 3. In Brazil, the results of the 
Family Budget Survey (POF 2008-2009) indicated 
that 50.1% of men and 48% of women were over-
weight, and that obesity prevalence was 12.4% in 
males and 16.9% in females 4.
Given this new scenario, characterized by 
high prevalence of obesity, cardiovascular dis-
eases appear as the leading public problem and 
diseases of the circulatory system are the prin-
cipal cause of deaths in Brazil as a whole (32%) 
and in all its geographic regions (Rede Interagen-
cial de Informações para a Saúde. Indicadores 
de Mortalidade. http://tabnet.datasus.gov.br/cgi/
deftohtm.exe?idb2009/c04.def).
Epidemiological studies have used body 
mass index (BMI) on a large scale to assess excess 
weight, but it is currently known that abdominal 
fat is more closely associated with increased risk 
of morbidity and mortality from cardiovascular 
disease and metabolic disorders such as dyslipi-
demia, hypertension, and diabetes mellitus 5,6.
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Regional obesity measures, including waist 
circumference (WC), waist/hip ratio, and waist/
height ratio provide estimates of central adipos-
ity, which in turn is related to the amount of vis-
ceral adipose tissue 6.
Despite the superiority of regional measures 
of body fat distribution over BMI, the results of 
different studies are inconclusive as to which 
anthropometric measure or indicator is best for 
predicting cardiovascular events and mortality. 
Some authors defend the use of waist/hip ratio to 
identify subjects at greatest risk of ischemic heart 
disease 7 and all-cause and cardiovascular mortal-
ity 8. Others show the superiority of WC associ-
ated (or not) with BMI for predicting all-cause 
and cardiovascular mortality 9. Various studies of 
Japanese individuals have indicated that waist/
height ratio corresponds more closely to meta-
bolic risk in subjects with and without general-
ized obesity 10,11,12.
Some ethnic groups have higher prevalence 
rates for excess weight. Studies of migrants have 
shown that the increase in body weight is associ-
ated with the variables involved in the process 
of adapting to the new environment, such as 
socio-cultural stress, altered diet patterns, and 
reduction in physical activity 13. For example, 
both in Brazil and the United States, Japanese 
emigrants when compared to individuals that 
remained in Japan show higher susceptibility to 
both increased body weight and accumulation 
of adipose tissue in the abdominal region, thus 
worsening their insulin sensitivity 14,15,16.
Therefore, the principal aim of the current 
study was to verify which measure used in the 
identification of abdominal obesity best predicts 
all-cause and cardiovascular mortality among 
Japanese-Brazilians, independently of the pres-
ence of generalized obesity.
Materials and methods
Data were used from the cohort study conducted 
by the Japanese-Brazilian Diabetes Study Group 
(JBDSG) among the Japanese-Brazilian commu-
nity in Bauru, São Paulo State, Brazil. The study 
was conducted with first-generation Japanese 
immigrants (Issei, born in Japan) and second-
generation (Nisei, born in Brazil and children 
of the first generation), of both genders, ages ≥ 
30 years. These individuals were examined three 
times (1993, 2000, and 2005-2007), using a meth-
odology described elsewhere 13,14,15,16,17.
Briefly, in 1993, after a local census per-
formed by the JBDSG, 1,518 Japanese-Brazilians 
were identified ranging in age from 40 to 79 years, 
of whom 1,137 were first- or second-generation 
(293 Issei and 764 Nisei). A systematic sample 
of 706 individuals was selected (all the Issei and 
one-third of the Nisei, with an additional 20% 
to compensate for possible losses) and 647 in-
dividuals participated in the study (91.6% of the 
selected individuals). In 1999-2000, after a new 
census in the community, 1,751 first- and second-
generation individuals ≥ 30 years of age living in 
Bauru were identified; 1,330 individuals partici-
pated (76% of the total population), of whom 394 
had also been examined in 1993. Among those 
that did not participate in the study, there was 
a higher proportion of males and individuals ≤ 
60 years of age, as compared to participants. The 
third phase of the research took place in 2005-
2007 and involved a community intervention 
study on lifestyle (diet and physical activity). All 
the participants were invited to participate in the 
second phase of the survey (1999-2000), along 
with their family members; a total of 736 indi-
viduals were evaluated (55.3%). Reasons for non-
participation included death (n = 101), change of 
address, or refusal (n = 493; Figure 1).
For the current study, complete information 
was available on the presence or absence of base-
line abdominal obesity and vital status at the end 
of the study (alive or dead) for 1,581 Japanese-
Brazilians (98.9% of those eligible); of these, 1,411 
subjects were alive at the end of the study. Of the 
170 deaths recorded during the study period 
(1993 to 2007), it was possible to identify the date 
and cause of death (based on a death certificate) 
in 154 cases (90.6%). Classification of cause of 
death used the 10th Revision of the International 
Classification of Diseases (ICD-10).
All the participants signed the informed 
consent form in the three study phases, and the 
study project was approved by the Institutional 
Review Board of the Federal University in São 
Paulo (UNIFESP), under case file 1907/06.
Similar research protocols were used in 1993 
and 2000 13,14,15,16,17. Initially, subjects were in-
formed of the study objectives by telephone (or 
in person). After agreeing to participate, two 
home visits were scheduled to apply the socio-
demographic and food survey questionnaires. 
On the day of the home interview, the interviewer 
scheduled the date for the physical examination 
and collection of laboratory samples. The socio-
demographic questionnaire was used to obtain 
baseline information on gender (female versus 
male), age (< 60 years versus ≥ 60 years), genera-
tion (first versus second), schooling (in Brazil 
and Japan, < 4 years of study versus ≥ 4 years), 
marital status (single/widowed/divorced versus 
married), smoking (none versus current or past), 
alcohol consumption (none versus current or 
past), history of illness (no/yes), working status 
Bevilacqua MR, Gimeno SGA1988
Cad. Saúde Pública, Rio de Janeiro, 27(10):1986-1996, out, 2011
(no/yes), and regular physical activity (seden-
tary/light versus moderate/intense).
On the day of the medical examination, in ad-
dition to the clinical and laboratory procedures, 
subjects answered a questionnaire on their per-
sonal health and use of medications. All subjects 
underwent a physical examination (including 
anthropometry and blood pressure) and labora-
tory tests (blood glucose and lipid profile, among 
others). The clinical examination was performed 
by physicians from the Department of Preventive 
Medicine, UNIFESP.
Body weight was measured in kilograms on 
a platform type scale (Filizola, São Paulo, Brazil) 
with a capacity of 200kg, accurate to 100g, placed 
on a flat surface and calibrated for each weigh-
ing. Height was measured with a manual stadi-
ometer attached to the wall, with a maximum 
height of 2m, accurate to 1cm (Sanny, São Paulo, 
Brazil). The study used World Health Organiza-
tion (WHO) 18 guidelines for classifying individu-
als by nutritional status according to BMI [weight 
in kg/(height in meters)2].
WC was measured with a non-stretchable 
tape measure at the level of the umbilicus, 
rounded to the nearest 0.1cm. This measure-
ment was taken with the subject standing erect, 
abdomen relaxed, arms hanging by the side, and 
Figure 1
Number of Japanese-Brazilians examined or lost to follow-up in the three phases of the Japanese-Brazilian Diabetes Study 
Group cohort. Bauru, São Paulo State, Brazil, 2007. 
1,137 first- and
second-generation
individuals identified
in the 1992 census
Examined in the third phase
(2005-2007): n = 736
Deaths: n = 101 (7.6%)
Refusals and changes of
address: n = 493 (37%) *
Deaths: n = 69 (10.6%) *
Changes of address: n = 57 (8.7%)
Refusals: n = 127 (19.7%)
Refusals and changes
of address:
n = 145 (13.1%)
1,751 first- and second-generation
individuals identified in the 1997 census
647 individuals participated
in the first phase
1,104 individuals were invited for
the second phase in 1999
Reexamined in 2000:
n = 394 (60.9%) Examined in 2000: n = 936 (84.4%)
1,330 individuals
* Deaths from 1993 to 2007: 69 + 101 = 170.
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feet together. Abdominal obesity was defined as 
WC ≥ 80cm and ≥ 90cm for women and men, re-
spectively, which are specific values for the Jap-
anese-descendent population 19,20. Hip circum-
ference was measured at the level of the greater 
femoral trochanters, around the most prominent 
area of the buttocks, with the tape measure held 
horizontally. Abdominal obesity, as assessed by 
waist/hip ratios, was defined as ≥ 0.95 for men 
and ≥ 0.80 for women 21.
Waist/height ratio was calculated as the ratio 
between WC (cm) and stature (cm). Abdominal 
obesity was defined in both genders as waist/
height ratio ≥ 0.5 10,11.
An automatic blood pressure monitor 
(HEM712C automatic digital device with a cuff 
adjusted to the brachial circumference; Omron 
Health Care, USA) was used to measure systolic 
(SBP) and diastolic blood pressure (DBP). After 
resting for 10 minutes, three SBP and DBP mea-
surements were taken, and the final value was 
defined as the mean of the latter two. Hyperten-
sion was defined as SBP ≥ 140mmHg or DBP ≥ 
90mmHg or regular use of medication for hyper-
tension 22.
Two blood samples were taken (fasting and 
two hours after a 75g oral glucose challenge). 
Glucose intolerance was defined according to 
WHO guidelines: normal (fasting blood glucose 
< 110mg/dL and 2-hour glucose < 140mg/dL), 
impaired fasting glucose – IFG (fasting glucose 
≥ 110mg/dL and < 126mg/dL and two-hour glu-
cose < 140mg/Dl), impaired glucose tolerance – 
IGT (fasting glucose < 126mg/dL and 2-hour glu-
cose ≥ 140mg/dL and < 200mg/dL), and diabetes 
(fasting glucose > 126mg/dL or 2-hour glucose 
>200mg/dL) 23.
Serum lipids were measured using enzymatic 
methods. Dyslipidemia was defined as total cho-
lesterol > 200mg/dL or triglycerides > 150mg/dL 
or HDL < 40mg/dL in males and < 50mg/dL in 
females or LDL > 130mg/dL 24.
Statistical data analysis
The dependent (outcome) variable was defined 
as status at the end of the study (alive versus all-
cause death or alive versus cardiovascular death). 
The independent or target variable was presence 
of abdominal obesity according to each of the 
three different anthropometric measures (WC, 
waist/hip ratio, and waist/height ratio).
Control variables included gender (male ver-
sus female), age (< 60 years versus ≥ 60 years), gen-
eration (second versus first), schooling in Brazil 
(≤ 4 years and > 4 years), marital status (single/
widowed/divorced versus married), BMI (under-
weight, normal, overweight, or obese), presence 
of dyslipidemia (yes/no), glucose tolerance (nor-
mal, IFG, IGT), presence of hypertension (yes/
no), smoking (current or past yes versus no), and 
regular alcohol consumption (yes/no).
Crude analysis provided mean and point val-
ues and 95% confidence intervals (95%CI) for 
continuous variables. The Student t test was used 
to verify the existence of differences between the 
means for socio-demographic, nutritional, and 
metabolic variables according to status at the 
end of the study (alive versus all-cause mortal-
ity or cardiovascular mortality). Mean and point 
all-cause and cardiovascular mortality rates and 
95%CI were calculated. The chi-square test and 
mortality rates ratios were used to identify as-
sociations between mortality and presence of 
abdominal obesity (according to WC, waist/hip 
ratio, and waist/height ratio), as well as the other 
categorical control variables.
Poisson multiple regression was used to ob-
tain ratios between mortality rates and presence 
of abdominal obesity according to the different 
criteria, adjusted for the control variables. Four 
models were constructed for each anthropomet-
ric measure, namely: (a) model 1: adjusted only 
for gender and age; (b) model 2: variables from 
model 1 plus generation, working status, school-
ing, and marital status; (c) model 3: variables in-
cluded in model 2 plus physical activity, alcohol 
consumption, and smoking; and (d) model 4: 
variables included in model 3 plus BMI, glucose 
tolerance, dyslipidemia, and hypertension.
Statistical analysis used Stata, version 10.0 
(Stata Corp., College Station, USA).
Results
Mean age of participants upon entering the co-
hort was 55.63 years (standard deviation – SD = 
11.80 years), and 61.3% (n = 960) were under 60 
years. Of the total (n = 1,565), 22.8% (n = 357) were 
first-generation and 53% (n = 829) were females.
At the end of 2007, 1,411 individuals (90.2%) 
were alive. Of the 154 (9.8%) deaths recorded 
during the study (with known date and cause 
of death), 74 (48.1%) were due to cardiovascu-
lar diseases, followed by different types of cancer 
(21.4%).
All-cause mortality rate was 10.68/thousand 
person-years (95%CI: 9.12-12.51/thousand per-
son-years). Table 1 shows the absolute figures 
and percentages for the demographic, metabolic, 
lifestyle, and anthropometric variables (at study 
baseline) according to vital status at the end of 
the study, in addition to the mortality rate ratio. 
Gender (male), age (≥ 60 years), generation (first), 
working status (no), years of schooling in Brazil 
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Table 1
Number, percentage of individuals, and mortality rate ratios (MRR, thousand person-years), point rates, and 95% confi dence intervals (95%CI) for baseline 
demographic, metabolic, lifestyle, and anthropometric variables according to vital status at the end of the study (alive or all-cause or cardiovascular mortality). 
Bauru, São Paulo State, Brazil, 2007.
Variable Alive (n = 1,411) All-cause mortality (n = 154) Cardiovascular mortality (n = 74)
n % n % MRR (95%CI) n % MRR (95%CI)
Gender
Female 771 54.6 58 37.7 1.00 27 36.5 1.00
Male 640 45.5 96 62.3 1.93 (1.38-2.72) 47 63.5 2.06 (1.26-3.44)
Age (year)
< 60 918 65.1 42 27.3 1.00 22 29.7 1.00
≥ 60 493 34.9 112 72.7 4.23 (2.94-6.18) 52 70.3 3.93 (2.34-6.79)
Generation
First 282 20.1 72 46.8 1.00 33 44.6 1.00
Second 1,118 79.9 82 53.2 0.38 (0.28-0.53) 41 55.4 0.40 (0.25-0.65)
Smoking
No 879 69.5 69 60.5 1.00 33 61.1 1.00
Yes 386 30.5 45 39.5 1.53 (1.03-2.26) 21 38.9 1.51 (0.83-2.69)
Alcohol consumption
No 887 65.3 86 67.2 1.00 43 71.7 1.00
Yes 472 34.7 42 32.8 0.99 (0.67-1.45) 17 28.3 0.81 (0.43-1.45)
Working status
No 636 45.3 105 68.2 1.00 51 68.9 1.00
Yes 769 54.7 49 31.8 0.40 (0.28-0.57) 23 31.1 0.38 (0.22-0.63)
Physical activity
Sedentary/Light 1,029 73.6 117 76.5 1.00 53 72.6 1.00
Active 369 26.4 36 23.5 0.97 (0.65-1.42) 20 27.4 1.19 (0.67-2.03)
Marital status
Single/Widowed/Divorced 306 21.8 31 20.1 1.00 15 20.3 1.00
Married 1,098 78.2 123 79.9 1.07 (0.71-1.63) 59 79.7 1.06 (0.59-2.01)
Schooling in Brazil (years)
≤ 4 589 50.0 94 64.0 1.00 46 66.7 1.00
> 4 589 50.0 52 36.0 0.58 (0.40-0.82) 22 33.3 0.51 (0.29-0.86)
BMI (kg/m2)
≤ 24.9 769 55.1 83 55.3 1.00 44 60.3 1.00
25-29.9 506 36.2 53 35.3 0.90 (0.51-1.59) 21 28.8 1.33 (0.79-2.23)
≥ 30 122 8.7 14 9.4 0.90 (0.50-1.62) 8 10.9 1.61 (0.71-3.63)
Abdominal obesity (WC)
< 80cm (F); < 90cm (M) 747 52.9 82 53.3 1.00 41 55.4 1.00
≥ 80cm (F); ≥ 90cm (M) 664 47.1 72 46.7 0.94 (0.67-1.31) 33 44.6 0.86 (0.53-1.39)
Abdominal obesity (waist/hip ratio)
< 0.85 (F); < 0.95 (M) 792 56.1 66 42.9 1.00 27 36.5 1.00
≥ 0.85 (F); ≥ 0.95 (M) 619 43.9 88 57.1 1.35 (0.97-1.88) 47 63.5 2.74 (1.06-2.91)
Abdominal obesity (waist/height ratio)
< 0.50 376 26.7 27 17.5 1.00 11 14.9 1.00
≥ 0.50 1,035 73.3 127 82.5 1.54 (1.01-2.45) 63 85.1 1.85 (0.97-3.89)
Glucose tolerance
Normal 392 27.8 41 26.8 1.00 20 27.0 1.00
IFG 361 25.6 15 9.8 0.63 (0.40-1.01) 8 10.8 1.32 (0.58-3.00)
IGT 269 19.1 32 20.9 0.44 (0.24-0.82) 11 14.9 1.50 (0.60-3.73)
Diabetes 389 27.5 65 42.5 1.41 (0.92-2.15) 35 47.3 3.29 (1.53-7.10)
(continues)
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Table 1 (continued)
Variable Alive (n = 1,411) All-cause mortality (n = 154) Cardiovascular mortality (n = 74)
n % n % MRR (95%CI) n % MRR (95%CI)
Arterial hypertension
No 923 65.7 73 47.7 1.00 32 43.2 1.00
Yes 483 34.3 80 52.3 2.10 (1.51-2.92) 42 56.8 2.55 (1.57-4.17)
Dyslipidemia *
No 232 16.5 28 18.3 1.00 9 12.2 1.00
Yes 1,177 82.5 125 81.7 0.92 (0.60-1.43) 65 87.8 1.47 (0.73-3.36)
BMI: body mass index; F: female; IFG: impaired fasting glucose; IGT: impaired glucose tolerance; M: male; WC: waist circumference.
* Total cholesterol > 200mg/dL or triglycerides > 150mg/dL or HDL < 40mg/dL for men and < 50mg/dL for women or LDL > 130mg/dL.
(≤ 4 years), and hypertension were risk factors for 
all-cause and cardiovascular mortality. Smoking 
(yes) and presence of abdominal obesity accord-
ing to waist/height ratio were only risk factors 
for all-cause mortality, while glucose intolerance 
(IGT) was a protective factor. Abdominal obesity 
according to waist/hip ratio and diabetes were 
risk factors for cardiovascular mortality.
Of the 1,565 individuals included in the study, 
47% showed baseline abdominal obesity accord-
ing to WC, 45.2% based on waist/hip ratio, and 
74.3% according to waist/height ratio. No sta-
tistically significant differences were observed 
between the percentage of individuals that died 
when comparing those with or without abdomi-
nal obesity according to WC (47.1% versus 52.9% 
for all causes, p = 0.990; 44.6% versus 55.4% for 
cardiovascular mortality, p = 0.684). According to 
classification by waist/hip ratio and waist/height 
ratio, there were more deaths among those 
with baseline abdominal obesity (waist/hip ra-
tio: 57.5% versus 42.5% for all-cause mortality, 
p = 0.001; 63.5% versus 36.5% for cardiovascu-
lar mortality, p = 0.001; waist/height ratio: 82.9% 
versus 17.1% for all-cause mortality, p = 0.012; 
85.1% versus 14.9% for cardiovascular mortality, 
p = 0.026).
Table 2 shows the mean values and respec-
tive 95%CI for baseline demographic, metabolic, 
lifestyle, and anthropometric variables according 
to vital status at the end of the study. Subjects 
that had died (from all causes or cardiovascular 
diseases), compared to those that were alive at 
the end of the study, showed higher mean age, 
more baseline abdominal obesity (according to 
WC, waist/hip ratio, or waist/height ratio), higher 
fasting and 2-hour blood glucose, higher SBP and 
DBP, and lower HDL.
Table 3 shows the mortality rate ratios ob-
tained through Poisson multiple regression anal-
ysis. Presence of abdominal obesity according to 
WC or waist/height ratio (yes/no) was not associ-
ated with the target outcomes, while this associa-
tion remained statistically significant for waist/
hip ratio (especially for cardiovascular mortal-
ity), even after adjusting simultaneously for other 
variables. Meanwhile, gender (male), age (≥ 60 
years), and hypertension were independent risk 
factors for all-cause and cardiovascular mortal-
ity, regardless of the respective anthropometric 
index. Absence of dyslipidemia was an indepen-
dent protective factor against all-cause and car-
diovascular mortality, regardless of the anthro-
pometric index.
Discussion
Few epidemiological cohort studies in Brazil 
have investigated associations between abdom-
inal obesity and morbidity and mortality from 
chronic non-communicable diseases, and such 
studies are non-existent among Japanese im-
migrants. The current study followed a cohort of 
individuals outside of their country of origin for 
14 years, which allowed evaluating the impact of 
environmental variables on mortality. In addi-
tion, the high proportion of subjects with com-
plete follow-up in the mortality study (> 90%) re-
inforces the results presented here. This study is 
particularly relevant to the extent that it focuses 
on a theme of growing interest in international 
research in recent decades.
Most of the published studies on associa-
tions between obesity and mortality in popula-
tion groups have only focused on the role of BMI 
9,25,26,27. However, it is known that lean individ-
uals can show increased risk of cardiovascular 
diseases and other metabolic and inflammatory 
disorders if they present accumulated fat in the 
abdominal region 28.
The mean baseline WC, waist/hip ratio, and 
waist/height ratio for Japanese-Brazilians were 
generally statistically higher (for waist/hip ra-
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tio and waist/height ratio) among individuals 
that died as compared to those that were alive 
at the end of the study. The prevalence rates for 
abdominal obesity according to WC, waist/hip 
ratio, and waist/height ratio were 47.1%, 45.3%, 
and 74.4%, respectively. This situation shows 
that although the group was not obese on aver-
age (mean BMI 24.4kg/m2), the high prevalence 
of abdominal obesity contributes to metabolic 
alterations in this community 6. However, in or-
der to compare this study’s findings with those 
of other researchers, it is necessary to take into 
account the cutoff points, gender, and ethnicity, 
among other factors.
In the current study, only waist/hip ratio re-
mained associated with cardiovascular mortality 
after adjusting for other variables such as gender, 
age, and hypertension. The use of waist/hip ra-
tio alone requires caution, since interpretation 
of the results has to take the measurement of two 
variables into account: waist and hips 5,9.
Various researchers defend the use of waist/
hip ratio as the best measure for identifying pres-
ence of abdominal obesity. According to such au-
thors, besides being associated with insulin resis-
tance, glucose intolerance, and increased cardio-
vascular risk, waist/hip ratio is a good predictor 
of the occurrence of coronary artery disease and 
correlates well with the amount of intra-abdomi-
nal adipose tissue 7,29,30,31,32,33.
According to the current study, Japanese-
Brazilians of both sexes with elevated waist/hip 
ratio (men ≥ 0.95 and women ≥ 0.80) had three 
times greater odds of dying from cardiovascular 
diseases. This result corroborates the findings of 
another study, in which individuals with elevated 
waist/hip ratio had a twofold risk of developing 
cardiovascular diseases; when a cutoff of 0.88 
was used, the risk increased to threefold 34.
Of the deaths recorded in this study, 48.1% 
were due to cardiovascular diseases, confirming 
the data showing that these are the most frequent 
Table 2
Mean values and 95% confi dence intervals (95%CI) for baseline demographic, metabolic, lifestyle, and anthropometric variables according to vital status at the 
end of the study (alive, all-cause mortality, cardiovascular mortality). Bauru, São Paulo State, Brazil, 2007.
Variable Alive (n = 1,411) All-cause mortality (n = 154) Cardiovascular mortality (n = 74)
Mean 95%CI Mean 95%CI p-value *.** Mean 95%CI p-value *.***
Age (years) 54.6 54.0-55.2 65.1 63.5-66.8 < 0.001 64.3 61.8-66.8 < 0.001
Weight (kg) 61.0 60.4-61.6 59.9 57.9-61.8 0.127 59.8 56.9-62.7 0.193
Height (m) 1.57 1.56-1.57 1.56 1.55-1.57 0.207 1.56 1.54-1.58 0.256
Body mass index (kg/m2) 24.8 24.6-25.1 24.5 23.8-25.1 0.160 24.6 23.7-25.5 0.702
Waist circumference (cm) 84.4 83.8-84.9 86.7 85.0-88.4 < 0.010 86.5 84.3-88.7 < 0.050
Waist/hip ratio 0.88 0.88-0.89 0.93 0.92-0.94 < 0.001 0.94 0.92-0.95 < 0.001
Waist/height ratio 0.54 0.53-0.54 0.56 0.55-0.57 < 0.010 0.56 0.54-0.57 < 0.050
Systolic blood pressure (mmHg) 129.3 128.1-130.5 147.6 135.7-
159.4
< 0.001 157.0 133.1-180.9 < 0.001
Diastolic blood pressure (mmHg) 79.0 78.2-79.8 86.2 74.0-98.4 < 0.010 95.3 70.1-120.5 < 0.001
Fasting glucose (mg/dL) 116.3 114.5-118.1 123.8 115.8-
131.8
< 0.010 128.5 115.4-141.6 < 0.010
2-hour glucose (mg/dL) 150.3 146.5-154.1 172.1 158.5-
185.8
< 0.001 179.7 157.7-201.7 < 0.001
Total cholesterol (mg/dL) 214.1 211.8-216.3 210.9 203.0-
218.8
0.197 216.8 205.0-228.5 0.298
HDL cholesterol (mg/dL) 47.4 46.8-48.0 44.5 42.6-46.5 < 0.010 45.2 42.2-48.3 0.047
LDL cholesterol (mg/dL) 134.4 132.4-136.4 129.9 123.4-
136.4
0.086 130.9 120.7-141.0 0.220
Triglycerides (mg/dL) 206.3 197.5-215.2 200.1 171.1-
229.2
0.335 232.3 176.8-287.9 0.106
* Student t test;
** All-cause mortality versus alive;
*** Cardiovascular mortality versus alive.
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Table 3
Mortality rate ratios (MRR), point rates, and 95% confi dence intervals (95%CI) obtained by Poisson multiple regression for presence of abdominal obesity (waist 
circumference – WC, waist/hip ratio, and waist/height ratio) and demographic, metabolic, lifestyle, and anthropometric variables. Bauru, São Paulo State, 
Brazil, 2007.
Independent variable All-cause mortality Cardiovascular mortality
MRR (95%CI) MRR (95%CI)
Abdominal obesity according to WC (yes/no)
Model 1 1.13 (0.81-1.56) 1.04 (0.65-1.66)
Model 2 1.20 (0.85-1.68) 1.13 (0.6-1.84)
Model 3 1.32 (0.86-2.02) 1.46 (0.76-2.80)
Model 4 1.14 (0.65-1.99) 1.53 (0.67-3.52)
Abdominal obesity according to waist/hip ratio (yes/no)
Model 1 1.53 (1.10-2.12) 2.06 (1.27-3.34)
Model 2 1.43 (1.02-2.00) 1.90 (1.15-3.16)
Model 3 1.32 (0.86-2.02) 2.50 (1.26-4.96)
Model 4 1.23 (0.77-1.98) 2.81 (1.32-6.00)
Abdominal obesity according to waist/height ratio (yes/no)
Model 1 1.36 (0.89-2.08) 1.64 (0.86-3.12)
Model 2 1.36 (0.88-2.11) 1.77 (0.88-3.57)
Model 3 1.57 (0.87-2.83) 2.27 (0.80-6.42)
Model 4 2.27 (0.80-6.42) 2.30 (0.76-6.97)
Model 1: adjusted only for gender and age; model 2: variables from model 1 plus generation, working status, schooling, and marital status; model 3: variables 
included in model 2 plus physical activity, alcohol consumption, and smoking; and (d) model 4: variables included in model 3 plus body mass index (BMI), 
glucose tolerance, dyslipidemia, and hypertension.
diseases in the Brazilian population. Despite the 
downward trend in cardiovascular mortality in 
Brazil and in the world, some projections indicate 
an increase in its relative importance in low- and 
middle-income countries. Greater longevity and 
a possible rise in the incidence of cardiovascu-
lar diseases due to the adoption of lifestyles with 
greater exposure to risk factors are considered 
the principal reasons for this increase 35.
Diseases of the circulatory system (cerebro-
vascular and ischemic heart diseases) contribute 
significantly as a causal group for mortality in all 
the geographic regions of Brazil. According to the 
Ministry of Health, the Southeast has the highest 
mortality rate due to diseases of the circulatory 
system (2.07 deaths per 1,000 inhabitants), while 
the mean for Brazil as a whole is 1.69 per 1,000. 
This study found 10.68 deaths from all causes 
per 1,000 inhabitants and 5.28 per 1,000 due to 
cardiovascular diseases. Cardiovascular diseases 
represent nearly one-third of all deaths and 65% 
of all deaths in the 30-69-year age bracket, affect-
ing the adult population in its most productive 
phase (Rede Interagencial de Informações para 
a Saúde. Indicadores de Mortalidade. http://tab
net.datasus.gov.br/cgi/deftohtm.exe?idb2009/
c04.def).
These data corroborate other studies in the 
Japanese-Brazilian community in Bauru, show-
ing that this population is at high risk for diabe-
tes, dyslipidemia, hypertension, cardiovascular 
disease, and metabolic syndrome 13,14,15,26.
In this study, as expected, individuals that 
died from all causes or from cardiovascular dis-
eases displayed a worse metabolic and anthropo-
metric profile. In particular, hypertension, dys-
lipidemia, male gender, and age ≥ 60 years were 
independent factors for all-cause and cardiovas-
cular mortality. Such findings are consistent with 
the majority of prospective studies in the litera-
ture 25,27. The findings also agree with the study 
among Japanese-Brazilians that participated in 
the first phase of the JBDSG project 36.
Some limitations to the study should be con-
sidered: (1) one cannot rule out the possibility of 
errors in the anthropometric measurements; at 
any rate, the choice of a standardized methodol-
ogy for collecting this information probably min-
imized the occurrence of this bias; (2) certain in-
dividual characteristics are known to change over 
time (e.g. weight and BMI variation, sedentary life-
style, diet, and smoking), and when ignored these 
changes can alter the research findings; however, 
it was not possible to evaluate this issue in the 
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current study, since not all the information needed 
for this purpose was available; and (3) although 
there were some losses to follow-up, they rep-
resented less than 10% of the sample and their 
impact on the results can thus be considered 
minimal.
Conclusion
Based on the findings, one can conclude that the 
prevalence of abdominal obesity among Japa-
nese-Brazilians was high, and that high values for 
waist/hip ratio served as a risk factor for cardio-
vascular mortality, independently of gender, age, 
and presence of hypertension or dyslipidemia, 
thus suggesting that for these individuals, waist/
hip ratio is the best predictor of mortality.
Resumo
O objetivo foi verificar qual medida antropométrica 
de obesidade abdominal melhor prediz mortalidade 
geral e por doenças cardiovasculares entre nipo-bra-
sileiros. Foram seguidos, por 14 anos, 1.581 sujeitos. 
Coletaram-se dados sociodemográficos, de estilo de vi-
da, metabólicos e antropométricos. Considerou-se vivo 
ou óbito ao final do estudo como variável dependente 
e a presença de obesidade abdominal por diferentes 
medidas na linha de base como variável independen-
te. Estimou-se o coeficiente de mortalidade e se usou o 
modelo de Poisson para obtenção das razões entre eles 
e a obesidade abdominal, ajustados simultaneamente 
às demais variáveis. O coeficiente de mortalidade foi 
de 10,68/mil pessoas-ano. O gênero masculino, a ida-
de ≥ 60 anos e ter hipertensão arterial foram fatores de 
risco independentes para mortalidade. Os resultados 
indicaram que entre nipo-brasileiros a prevalência de 
obesidade abdominal foi elevada e que a razão cintura 
quadril foi a medida que apresentou maior capacida-
de de predizer a mortalidade, especialmente cardio-
vascular, entre tais indivíduos.
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